Yes, nuclear pleomorphism can be quantified using various grading systems. One common method is the Nottingham grading system for breast cancer, which scores nuclear pleomorphism on a scale from 1 to 3. A score of 1 indicates mild pleomorphism, 2 indicates moderate pleomorphism, and 3 indicates severe pleomorphism. These scores are combined with other histological features to determine the overall tumor grade.